Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2024

BUY
$7.31 - $11.18 $801,592 - $1.23 Million
109,657 New
109,657 $827 Million
Q4 2022

May 10, 2024

SELL
$9.48 - $14.52 $29,236 - $44,779
-3,084 Reduced 2.74%
109,657 $1.11 Million
Q4 2022

Mar 22, 2023

SELL
$9.48 - $14.52 $29,236 - $44,779
-3,084 Reduced 2.74%
109,657 $1.11 Million
Q4 2022

Feb 15, 2023

SELL
$9.48 - $14.52 $29,236 - $44,779
-3,084 Reduced 2.74%
109,657 $1.11 Million
Q3 2022

May 10, 2024

BUY
$9.2 - $13.68 $32,696 - $48,618
3,554 Added 3.25%
112,741 $1.12 Million
Q3 2022

Jun 14, 2023

BUY
$9.2 - $13.68 $28,372 - $42,189
3,084 Added 2.81%
112,741 $1.12 Million
Q3 2022

Mar 22, 2023

BUY
$9.2 - $13.68 $32,696 - $48,618
3,554 Added 3.25%
112,741 $1.12 Million
Q3 2022

Nov 14, 2022

BUY
$9.2 - $13.68 $32,696 - $48,618
3,554 Added 3.25%
112,741 $1.12 Million
Q2 2022

May 10, 2024

BUY
$5.72 - $10.65 $624,549 - $1.16 Million
109,187 New
109,187 $1.16 Million
Q2 2022

Jun 20, 2023

SELL
$5.72 - $10.65 $2,688 - $5,005
-470 Reduced 0.43%
109,187 $1.16 Million
Q2 2022

Mar 22, 2023

SELL
$5.72 - $10.65 $2,688 - $5,005
-470 Reduced 0.43%
109,187 $1.16 Million
Q2 2022

Aug 11, 2022

BUY
$5.72 - $10.65 $624,549 - $1.16 Million
109,187 New
109,187 $1.16 Million

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $841M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.